Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

IV iron

Phase 3Small molecule

IV iron is one of 84 small molecule programs targeting Intelligence. It is currently in Phase 3.

3

Indications

11

Total Trials

2

Active Trials

83

Competitors

Pipeline

Status by Indication[3][1]

Indication

Oxidative StressActive, not recruiting

Ovarian CancerNot yet recruiting

Oxidative StressPreclinical

Active, not recruiting

Ovarian CancerPhase 3

Not yet recruiting

Competition

Competitive Landscape

209 competitors in Ovarian Cancer

#DrugCompanyPhaseTrials

Avastin

Gemzar

Johnson & Johnson

Keytruda

Hycamtin

Pegylated Liposomal Doxorubicin

Platinol

MMcNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

Cytoxan

BBaxter Healthcare Corporation

Adriamycin

Imfinzi

Opdivo

Bristol-Myers Squibb

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q4 2027

Bleeding Disorder

NCT07083583

Q4 2029

Phase 3Not yet recruiting

Ovarian Cancer

NCT06248749

Clinical

Trials by Indication[1]

Chronic Kidney Disease2 trials

A Phase 3b Study of Erythropoietin Drugs Using a Specified Dosing Algorithm in Patients With Chronic Kidney Disease on Hemodialysis

Completed· Pfizer logo

Pfizer·Phase 3·NCT02504294·432 enrolled

A Clinical Trial of Oral Versus IV Iron in Patients With Chronic Kidney Disease

Terminated·IIndiana University·Phase 4·NCT00830037·136 enrolled

Hepatectomy1 trial

HepciFer Study: Hepcidin Overexpression After Hepatectomy : Does Iron Supplementation Make Sense ?

Completed·UUniversity Hospital, Geneva·Phase 3·NCT02631980·50 enrolled

Oxidative Stress1 trial

The Effect of Pomegranate Juice (PJ) on Oxidative Stress Biomarkers During Treatment With IV Iron During One Dialysis Session

Completed·WWestern Galilee Hospital-Nahariya·N/A·NCT02107053·25 enrolled

Catheter1 trial

The Effect of IV PAPAVERINE 80 mg Prior to Catheter Balloon Insertion on Bishop Score and Pain

Unknown status·WWestern Galilee Hospital-Nahariya·N/A·NCT05759364·128 enrolled

Randomized1 trial

A Randomized Study to Compare the Dosing Schedule of INFeD in Anemic Patients.

Withdrawn·SSutter Gould Medical Foundation·Phase 4·NCT03286205

5 more indications

Anemia1 trial

Study of Roxadustat (FG-4592) to Correct Anemia in Newly Initiated Dialysis Participants Not on Erythropoiesis-Stimulating Agent Treatment

Completed·KKyntra Bio·Phase 2·NCT01414075·60 enrolled

Ovarian Cancer1 trial

Effect of Intravenously Iron Infusion on the Prevention and Treatment of Anemia in Ovarian Cancer

Not yet recruiting·UUniversity of Saskatchewan·Phase 3·NCT06248749·200 enrolled

Intelligence1 trial

Artificial Intelligence for Optimal Anemia Management in End-stage Renal Disease: The Anemia Control Model (ACM) Trial

Terminated·VVifor Fresenius Medical Care Renal Pharma·N/A·NCT03214627·88 enrolled

Bleeding Disorder1 trial

Impact of IV Iron on Bleeding Symptoms in Iron Deficient Patients With Inherited Bleeding Disorders: a Single-arm Prospective Observational Study

Recruiting·NNicoletta C Machin··NCT07083583·40 enrolled

Postpartum1 trial

Prevention of Iron Deficiency Anemia Post-delivery (PRIORITY Trial): A Randomized Controlled Trial of the Global Network for Women's and Children's Health Research

Completed·NNICHD Global Network for Women's and Children's Health·Phase 3·NCT05590260·4,857 enrolled

Sources

References

[1]
ClinicalTrials.gov — 11 trial records for IV iron. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — IV iron compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for IV iron. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Pfizer company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 3[1]
Company: Pfizer

Related News